---
figid: PMC7352357__cancers-12-01410-g001
figlink: pmc/articles/PMC7352357/figure/cancers-12-01410-f001/
number: Figure 1
caption: Cholesterol metabolism and key oncogenic pathways related to cancer development.
  (a) Cholesterol de novo biosynthesis. Starting from three molecules of acetyl-coenzyme
  A (CoA), cholesterol is synthesized in more than 20 enzymatic steps, whereas 3-hydroxy-3-methylglutaryl-CoA
  reductase (HMGCR) and squalene epoxidase (SQLE) act as rate-limiting enzymes. (b)
  Systematic diagram showing the cholesterol metabolism in relation to key oncogenic
  molecular pathways. Sterol-regulatory element binding protein 2 (SREBP2) regulates
  the transcriptional activity of cholesterol biosynthesis genes, low density lipoprotein
  receptor (LDLR)-mediated cholesterol influx, and Nod-like receptor protein 3 (NLRP3)
  inflammasome-associated inflammation. Embedded in SREBP2 gene, microRNA (miRNA)-33
  can positively regulate SREBP2 expression. The over-activated cholesterol biosynthesis
  contributes to uncontrolled cell growth. Overexpressed proprotein-convertase-subtilisin-kexin
  type-9 (PCSK9) facilities the lysosomal degradation of LDLR, induces hypercholesterolemia,
  and eventually leads to the development of hepatocellular carcinoma. Excess cholesterol
  is exported via ATP-binding cassette (ABC) subfamily A member 1 (ABCA1) under liver
  X receptor (LXR) activation. However, in cancercells, ABCA1 is prohibited by the
  phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin
  complex 1 (mTORC1) pathway. The overall retention of intracellular cholesterol facilitates
  acyl-CoA:cholesteryl acyltransferase 1 (ACAT1), converting cholesterol into cholesteryl
  esters, leading to the development of different types of cancer. ABCA1 can also
  be inhibited by miRNA-27 and miRNA-183. TP53-mediated SREBP2 activation increases
  the production of farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate
  (GGPP) in the mevalonate pathway, resulting in prenylation of small Ras family GTPases
  and their downstream effectors. An increased SQLE level under high nuclear SREBP2
  (nSREBP2) induction inhibits phosphatase and tensin homolog (PTEN) activity and
  sequentially allows the PI3K/Akt/mTORC1 signaling cascade. Lastly, cholesterol or
  its oxidative derivatives activate Smoothened receptor (SMO) in the sonic hedgehog
  (SHH) pathway. The overall alterations in these pathways increase the proliferation
  rate and the migration and invasion capacities, allow cell survival, and induce
  tumor formation.
pmcid: PMC7352357
papertitle: 'The Pivotal Role of the Dysregulation of Cholesterol Homeostasis in Cancer:
  Implications for Therapeutic Targets.'
reftext: Etienne Ho Kit Mok, et al. Cancers (Basel). 2020 Jun;12(6):1410.
pmc_ranked_result_index: '101492'
pathway_score: 0.9540095
filename: cancers-12-01410-g001.jpg
figtitle: Cholesterol metabolism and key oncogenic pathways related to cancer development
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7352357__cancers-12-01410-g001.html
  '@type': Dataset
  description: Cholesterol metabolism and key oncogenic pathways related to cancer
    development. (a) Cholesterol de novo biosynthesis. Starting from three molecules
    of acetyl-coenzyme A (CoA), cholesterol is synthesized in more than 20 enzymatic
    steps, whereas 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) and squalene epoxidase
    (SQLE) act as rate-limiting enzymes. (b) Systematic diagram showing the cholesterol
    metabolism in relation to key oncogenic molecular pathways. Sterol-regulatory
    element binding protein 2 (SREBP2) regulates the transcriptional activity of cholesterol
    biosynthesis genes, low density lipoprotein receptor (LDLR)-mediated cholesterol
    influx, and Nod-like receptor protein 3 (NLRP3) inflammasome-associated inflammation.
    Embedded in SREBP2 gene, microRNA (miRNA)-33 can positively regulate SREBP2 expression.
    The over-activated cholesterol biosynthesis contributes to uncontrolled cell growth.
    Overexpressed proprotein-convertase-subtilisin-kexin type-9 (PCSK9) facilities
    the lysosomal degradation of LDLR, induces hypercholesterolemia, and eventually
    leads to the development of hepatocellular carcinoma. Excess cholesterol is exported
    via ATP-binding cassette (ABC) subfamily A member 1 (ABCA1) under liver X receptor
    (LXR) activation. However, in cancercells, ABCA1 is prohibited by the phosphoinositide
    3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin complex 1
    (mTORC1) pathway. The overall retention of intracellular cholesterol facilitates
    acyl-CoA:cholesteryl acyltransferase 1 (ACAT1), converting cholesterol into cholesteryl
    esters, leading to the development of different types of cancer. ABCA1 can also
    be inhibited by miRNA-27 and miRNA-183. TP53-mediated SREBP2 activation increases
    the production of farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate
    (GGPP) in the mevalonate pathway, resulting in prenylation of small Ras family
    GTPases and their downstream effectors. An increased SQLE level under high nuclear
    SREBP2 (nSREBP2) induction inhibits phosphatase and tensin homolog (PTEN) activity
    and sequentially allows the PI3K/Akt/mTORC1 signaling cascade. Lastly, cholesterol
    or its oxidative derivatives activate Smoothened receptor (SMO) in the sonic hedgehog
    (SHH) pathway. The overall alterations in these pathways increase the proliferation
    rate and the migration and invasion capacities, allow cell survival, and induce
    tumor formation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HMGCR
  - SQLE
  - ALB
  - APOA2
  - APOA1
  - APOE
  - CLU
  - TP53
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - LDLR
  - HRAS
  - KRAS
  - NRAS
  - PTEN
  - SMO
  - ABCA1
  - AKT2
  - AKT3
  - AKT1
  - MAPK3
  - MAPK1
  - GLI1
  - ACAT1
  - PCSK9
  - STAT3
  - INSIG1
  - MBTPS2
  - MBTPS1
  - NLRP3
  - SCAP
  - SREBF2
  - Cholesterol
  - Farnesyl
  - Squalene
  - Acetyl-CoA --- HMG-COAMevalonate---Farnesyl-PP Squalene 2,3-epoxysqualene-Lanosterol
  - Geranylgeranyl
  - cholesterol
  - Cholesteryl esters
  - cancer
  - Hepatocellular carcinoma
  - glioblastoma
  - breast cancer
  - carcinoma
genes:
- word: (HMGCR
  symbol: HMGCR
  source: hgnc_symbol
  hgnc_symbol: HMGCR
  entrez: '3156'
- word: SQLE
  symbol: SQLE
  source: hgnc_symbol
  hgnc_symbol: SQLE
  entrez: '6713'
- word: HDL/ApoA-I
  symbol: HDL
  source: bioentities_symbol
  hgnc_symbol: ALB
  entrez: '213'
- word: HDL/ApoA-I
  symbol: HDL
  source: bioentities_symbol
  hgnc_symbol: APOA2
  entrez: '336'
- word: HDL/ApoA-I
  symbol: HDL
  source: bioentities_symbol
  hgnc_symbol: APOA1
  entrez: '335'
- word: HDL/ApoA-I
  symbol: HDL
  source: bioentities_symbol
  hgnc_symbol: APOE
  entrez: '348'
- word: HDL/ApoA-I
  symbol: HDL
  source: bioentities_symbol
  hgnc_symbol: CLU
  entrez: '1191'
- word: SQLE
  symbol: SQLE
  source: hgnc_symbol
  hgnc_symbol: SQLE
  entrez: '6713'
- word: TP53
  symbol: TP53
  source: hgnc_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: LDLR
  symbol: LDLR
  source: hgnc_symbol
  hgnc_symbol: LDLR
  entrez: '3949'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: SMO
  symbol: SMO
  source: hgnc_symbol
  hgnc_symbol: SMO
  entrez: '6608'
- word: АВСА1
  symbol: ABCA1
  source: hgnc_symbol
  hgnc_symbol: ABCA1
  entrez: '19'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: GLI-1
  symbol: GLI1
  source: hgnc_symbol
  hgnc_symbol: GLI1
  entrez: '2735'
- word: ACAT1
  symbol: ACAT1
  source: hgnc_symbol
  hgnc_symbol: ACAT1
  entrez: '38'
- word: PCSK9
  symbol: PCSK9
  source: hgnc_symbol
  hgnc_symbol: PCSK9
  entrez: '255738'
- word: PCSK9
  symbol: PCSK9
  source: hgnc_symbol
  hgnc_symbol: PCSK9
  entrez: '255738'
- word: PCSK9
  symbol: PCSK9
  source: hgnc_symbol
  hgnc_symbol: PCSK9
  entrez: '255738'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: LDLR
  symbol: LDLR
  source: hgnc_symbol
  hgnc_symbol: LDLR
  entrez: '3949'
- word: INSIG1
  symbol: INSIG1
  source: hgnc_symbol
  hgnc_symbol: INSIG1
  entrez: '3638'
- word: PCSK9
  symbol: PCSK9
  source: hgnc_symbol
  hgnc_symbol: PCSK9
  entrez: '255738'
- word: S2P
  symbol: S2P
  source: hgnc_alias_symbol
  hgnc_symbol: MBTPS2
  entrez: '51360'
- word: S1P
  symbol: S1P
  source: hgnc_alias_symbol
  hgnc_symbol: MBTPS1
  entrez: '8720'
- word: NLRP3
  symbol: NLRP3
  source: hgnc_symbol
  hgnc_symbol: NLRP3
  entrez: '114548'
- word: SCAP
  symbol: SCAP
  source: hgnc_symbol
  hgnc_symbol: SCAP
  entrez: '22937'
- word: SREBP2
  symbol: SREBP2
  source: hgnc_alias_symbol
  hgnc_symbol: SREBF2
  entrez: '6721'
chemicals:
- word: Cholesterol
  source: MESH
  identifier: D002784
- word: Farnesyl
  source: MESH
  identifier: C042455
- word: Squalene
  source: MESH
  identifier: D013185
- word: Acetyl-CoA --- HMG-COAMevalonate---Farnesyl-PP Squalene 2,3-epoxysqualene-Lanosterol
  source: MESH
  identifier: D007810
- word: Geranylgeranyl
  source: MESH
  identifier: C002963
- word: cholesterol
  source: MESH
  identifier: D002784
- word: Cholesteryl esters
  source: MESH
  identifier: D002788
diseases:
- word: cancer
  source: MESH
  identifier: D009369
- word: Hepatocellular carcinoma
  source: MESH
  identifier: D006528
- word: glioblastoma
  source: MESH
  identifier: D005909
- word: breast cancer
  source: MESH
  identifier: D001943
- word: carcinoma
  source: MESH
  identifier: D002277
---
